🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the manufacturers of Tylenol, claiming the firms hid alleged dangers that the pain reliever created to pediatric neurological development.

The lawsuit follows four weeks after President Donald Trump promoted an unverified association between taking acetaminophen - referred to as paracetamol - throughout gestation and autism in young ones.

The attorney general is suing Johnson & Johnson, which formerly manufactured the medication, the exclusive pain medication approved for expectant mothers, and the current manufacturer, which presently makes it.

In a official comment, he claimed they "misled consumers by gaining financially from discomfort and pushing pills without regard for the dangers."

Kenvue asserts there is no credible evidence linking Tylenol to autism.

"These companies lied for decades, deliberately risking numerous people to increase profits," the attorney general, a Republican, stated.

The manufacturer commented that it was "very worried by the dissemination of inaccurate information on the reliability of acetaminophen and the possible consequences that could have on the well-being of American women and children."

On its online platform, the company also mentioned it had "consistently assessed the relevant science and there is no credible data that indicates a verified association between consuming acetaminophen and autism."

Organizations representing medical professionals and healthcare providers agree.

The leading OB-GYN organization has said acetaminophen - the primary component in acetaminophen - is one of the few options for pregnant women to treat discomfort and elevated temperature, which can present serious health risks if left untreated.

"In over twenty years of investigation on the use of acetaminophen in pregnancy, not a single reputable study has definitively established that the consumption of paracetamol in any period of gestation results in neurodevelopmental disorders in offspring," the organization said.

This legal action mentions recent announcements from the former administration in asserting the medication is potentially dangerous.

Last month, the former president raised alarms from health experts when he advised pregnant women to "resist strongly" not to consume Tylenol when ill.

The FDA then released a statement that doctors should contemplate reducing the usage of Tylenol, while also stating that "a direct connection" between the drug and autism spectrum disorder in children has not been established.

The Health Department head Kennedy, who supervises the FDA, had vowed in spring to initiate "comprehensive study program" that would establish the source of autism in a short period.

But authorities warned that discovering a sole reason of autism spectrum disorder - thought by researchers to be the result of a intricate combination of inherited and surrounding conditions - would prove challenging.

Autism is a category of permanent neurological difference and disability that affects how persons perceive and engage with the environment, and is identified using physician assessments.

In his court filing, Paxton - aligned with the former president who is seeking federal office - alleges Kenvue and J&J "willfully ignored and tried to quiet the research" around paracetamol and autism.

The case seeks to make the companies "eliminate any commercial messaging" that states acetaminophen is secure for expectant mothers.

The court case parallels the concerns of a assembly of mothers and fathers of young ones with autism spectrum disorder and ADHD who filed suit against the manufacturers of Tylenol in recently.

Judicial authorities dismissed the legal action, declaring investigations from the plaintiffs' authorities was not conclusive.